Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why Shares of Momenta Pharmaceuticals, Inc. Got Their Mojo Back Today

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Momenta Pharmaceuticals  (NASDAQ: MNTA  ) are trading up 11% after moving higher all day following news released after yesterday's close that Teva Pharmaceuticals (NYSE: TEVA  ) has lost its bid to block generic versions of Copaxone from hitting the market.

So what: Copaxone, which treats multiple sclerosis, is Teva's biggest blockbuster and its best cash cow, but its patent will expire in less than two weeks. Other drugmakers have been eagerly waiting in the wings with generic formulations. Momenta is one of these competitors, and is expected to roll out its generic Copaxone by the end of the month now that all legal roadblocks have been removed.

Now what: Copaxone brought Teva roughly $4.3 billion in sales last year, and gaining a mere 10% of those sales (with a much higher share of the drug's total sales, of course) would increase Momenta's annual revenue more than tenfold.

Momenta shares have been been zig-zagging for years as investors wait for the company to get something out there, and its Copaxone generic should, at the very least, give it a stronger revenue stream. However, it's a bit early to predict just how much stronger that revenue stream will be. Dig a little deeper to see if Momenta finally has the momentum you need from your biotech investments.

Momenta shares are having a great day -- but can they keep up with this top stock?
Give me five minutes and I'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks 1 stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2959691, ~/Articles/ArticleHandler.aspx, 9/2/2015 11:06:58 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Alex Planes

Alex Planes specializes in the deep analysis of tech, energy, and retail companies, with a particular focus on the ways new or proposed technologies can (and will) shape the future. He is also a dedicated student of financial and business history, often drawing on major events from the past to help readers better understand what's happening today and what might happen tomorrow.

Connect with Alex on LinkedIn or Twitter for more news and insight:

View Alex Planes's profile on LinkedIn

Today's Market

updated Moments ago Sponsored by:
DOW 16,156.06 97.71 0.61%
S&P 500 1,923.44 9.59 0.50%
NASD 4,665.59 29.48 0.64%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/2/2015 10:50 AM
MNTA $19.02 Up +0.13 +0.69%
Momenta Pharmaceut… CAPS Rating: *****
TEVA $63.58 Up +0.40 +0.63%
Teva Pharmaceutica… CAPS Rating: *****